About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 199 record(s)
Req # A-2020-001544
The recordings or word-for-word transcripts of technical briefings pertaining to COVID-19 from Health Canada and the Public Health Agency of Canada. Media advisories of these technical briefings are posted on Canada.ca. Timeline: January 1, 2020 to January 11, 2021.Organization: Health Canada
October 2021
Req # A-2020-001609
The annual number of registration certificates issues by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, in each province and territory. The number of inspections Health Canada conducted of production sites related to the registration certificates issued under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, in each province and territory. Period covered: 2015, 2016, 2017, 2018, 2019 and 2020.Organization: Health Canada
October 2021
Req # A-2020-001723
Media lines involving Dominique Baker's travel plans, relation to Air Canada and internal reactions to related news stories.Organization: Health Canada
October 2021
Req # A-2021-000047
An aggregated list of all non-cannabis ingredients that have or are used in inhalable cannabis extracts, as well as the frequency of their use.Organization: Health Canada
October 2021
Req # A-2021-000077
Health Canada Inspection Report of the Hyperimmune (plasma) manufacturing facilities of Emergent Biosolutions Inc., Winnipeg Manitoba, Canada Dates: Most recent Inspection report (2020).Organization: Health Canada
October 2021
Req # A-2021-000126
Copies of records previously processed under the following requests: A-2019-001934: Documents, procedures, presentations or assessment tools used by Health Canada when assessing compliance with promotion prohibitions under the Cannabis Act. A-2019-001935: Documents, procedures, presentations or assessment tools considered by Health Canada when assessing licence amendments pursuant to the Cannabis Act. A-2019-001936: Current inspection checklists and/or procedures used by field inspectors during inspections of facilities licenced pursuant to the Cannabis Act.Organization: Health Canada
October 2021
Req # A-2021-000127
Records of the Natural Health Product licence application for Organic Prebioitic Fibre Kids (Natural Product Number (NPN) 80092946). Specifically the studies or references used to support the recommended uses or purposes in both subpopulations (adults and children).Organization: Health Canada
October 2021
Req # A-2021-000318
Data from medical device incident reporting for all medical devices from February 3, 2020 until June 2, 2021 with the following information or fields: Sex (including null or unknown responses), Incident ID, Device, Device Type, Company Name, Hazard Severity, Description, Code Type and Receipt Date.Organization: Health Canada
October 2021
Req # A-2021-000327
The name of the manufacturer and the formulation type (e.g. immediate-release, or extended-release) of each drug product that is the subject of a submission for Tacrolimus on the list of Generic Submissions Under Review.Organization: Health Canada
October 2021
Req # A-2021-000392
The 2 applicants and the format of the product (e.g. capsule, topical, etc) that have a pending Abbreviated New Drug Submission (ANDS) as of June 2021 with Health Canada for a tacrolimus generic in the therapeutic area of immunosuppressants as indicated in the Generic Submissions Under Review (GSUR) public list.Organization: Health Canada
October 2021